Upon reviewing repeated prostate cancer screenings, researchers observed the absence of suspicious MRI findings in over 86% of men who had prostate-specific antigen (PSA) levels of 3 ng/mL or higher ...

A large screening trial showed that using prostate-specific antigen density (PSAD) before MRI prevented overdiagnosis and lowered resource use while preserving the detection of clinically significant ...

Whole-body screening MRI (wb-MRI) for asymptomatic patients has become a relevant topic for U.S. cancer centers. There is a growing number of for-profit centers offering wb-MRI scans for asymptomatic ...

Dr Ray O’Connor takes a look at recent clinical articles on screening, particularly with respect to cervical and prostate ...

Campaigners are calling for a national prostate screening programme to prevent deaths and save money Prostate cancer is the most common cancer in men in the UK, with approximately 55,000 new cases ...

Prostate cancer incidence is predicted to double to 2·9 million cases by 2040. Men diagnosed with clinically significant prostate cancer have many effective treatment options, but questions remain ...

EDITOR’S NOTE: Dr. Jamin Brahmbhatt is a urologist and robotic surgeon with Orlando Health and an assistant professor at the University of Central Florida’s College of Medicine. When I learned that ...

If there is one thing that the COVID pandemic taught us, it was the lack of flexibility, nimbleness and the frequent inaccuracy or out of datedness of superimposed guidelines. I must confess that as a ...